May 1, 2019
6:00 – 10:00 p.m.
As a highly experienced physician executive, Dr. Clancy has held several leadership positions at VHA. In her current role, she works to foster collaboration between the VA and its affiliates. Previously, as VHA’s Executive-in-Charge, she oversaw a health system delivering care to more than 9 million veterans. Before coming to VHA, Dr. Clancy was Director of the Agency for Healthcare Research and Quality for 10 years. In these influential roles, she has worked to enhance access to and quality of care for women.
A public relations veteran of nearly 40 years, Mr. Seng launched Spectrum Science Communications 22 years ago and led its development into a top-tier, award-winning health and life sciences communications firm. He also founded GLOBALHealthPR, the largest independent health and science communications agency partnership worldwide. Mr. Seng was a longtime SWHR Board member and has earned numerous honors for his work in science/health communications.
With 30+ years of neuroscience research experience, Dr. Xu joined Amgen in 2016 as a key contributor in building the company’s neuroscience strategy. She is a co-inventor for the first FDA-approved preventive migraine treatment and has aided in the discovery and development of other therapeutics, including for schizophrenia and sleep disorders. Her areas of focus include neurodegeneration, psychiatry disorders, migraine, and analgesia.